The global needle-free drug delivery devices market has the potential to grow by USD 10.23 billion during 2020-2024 and the market’s growth momentum will accelerate throughout the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by product (inhalers, transdermal patches, and jet injectors) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including 3M Co., Antares Pharma Inc., Becton, Dickinson and Co., Enesi Pharma Ltd., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Mylan NV, Novartis AG, PharmaJet Inc., and Valeritas Holdings Inc.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of needle-free drug delivery devices market

Request a FREE sample now!

Market Competitive Analysis

The needle-free drug delivery devices market is currently fragmented, and the degree of fragmentation will decrease during the forecast period. Market vendors are focusing on strategic alliances and launching new products to expand their geographical reach and strengthen their position in the needle-free drug delivery devices market. 3M Co., Antares Pharma Inc., and Becton are some of the major market participants. Although the growing prevalence of chronic diseases will offer immense growth opportunities, the high costs associated with needle-free drug delivery devices will challenge the growth of the market participants. To increase their needle-free drug delivery devices market share, companies should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this needle-free drug delivery devices market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this needle-free drug delivery devices market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading needle-free drug delivery device companies, including:

• 3M Co.
• Antares Pharma, Inc.
• Becton, Dickinson and Co.
• Enesi Pharma Ltd.
• GlaxoSmithKline Plc
• Inovio Pharmaceuticals Inc.
• Mylan NV
• Novartis AG
• PharmaJet Inc.
• Valeritas Holdings Inc.

Needle-free Drug Delivery Devices Market: Segmentation by Region

For more insights on the market share of various regions Request for a FREE sample now!

North America was the largest market for needle-free drug delivery devices in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. Increasing prevalence of chronic conditions, the development of advanced products, and rising partnerships by vendors are some of the significant factors responsible for needle-free drug delivery devices market growth in this region.

Over 39% of the market’s growth will originate from North America during the forecast period. The US is an essential market for needle-free drug delivery devices in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.

Needle-Free Drug Delivery Devices Market: Segmentation by Product

Request for a FREE sample and get more information on the market contribution of various product segments

Inhalers are portable and lightweight and can deliver medications to the airways immediately. The high incidence of asthma and the rising awareness about inhalers are some of the factors driving the growth of the needle-free drug delivery devices market in this segment.

Market growth in this segment will be slower than the growth of the market in the transdermal patches and jet injectors segments. This report provides an accurate prediction of the contribution of all the segments to the growth of the needle-free drug delivery devices market size.

Needle-free Drug Delivery Devices Market: Key Drivers and Trends

The increasing prevalence of chronic diseases will be a significant factor in driving the growth of the needle-free drug delivery devices market. There is a growing prevalence of various chronic diseases such as diabetes and asthma. The demand for needle-free drug delivery devices will especially increase due to the high incidence of type 1 diabetes in children who require regular administration of insulin. Growing pollution and respiratory infections have also contributed to the rising rates of asthma. Needle-free drug delivery devices are widely used for the treatment of asthma as it helps in the immediate administration of asthmatic medications. With the increasing prevalence of chronic diseases, the demand for needle-free drug delivery devices will also grow.

• Market vendors are focusing on the development of innovative and advanced needle-free drug delivery devices that facilitate the process of drug administration.
• The integration of software with needle-free drug delivery devices will help patients to adhere to their medication regimen, allow physicians to analyze the condition of their patients, and improve the management of chronic respiratory diseases, such as asthma.
• The development of digital solutions for the treatment of asthma and COPD will help patients to personalize the management of chronic respiratory diseases.
• Technological advances, which is one of the critical needle-free drug delivery devices market trends, will have a positive impact on the growth of the market.
• During 2020-2024, the needle-free drug delivery devices market will grow at a CAGR of over 4%.

Request for a FREE sample now!

Needle-Free Drug Delivery Devices Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will accelerate the growth of the needle-free drug delivery devices market during the next five years
• Precise estimation of the global needle-free drug delivery devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the needle-free drug delivery devices industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of needle-free drug delivery devices vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch